The most sought-after scientists in biopharma rarely post their resumes to LinkedIn. They don’t have to. Their work announces them […]

When a European patent dies — formally, irrevocably, at the hands of the European Patent Office’s Technical Board of Appeal

When Johnson & Johnson’s multiple myeloma franchise Darzalex (daratumumab) generated roughly $10 billion in global revenue in 2024, it stood

We rarely know where our medicines originate. The global pharmaceutical supply chain is an opaque network of chemical synthesis facilities,

1. Why Patent Expiry Forecasting Is a Revenue-Critical Discipline ‘Between 2025 and 2030, approximately 190 drugs will lose market exclusivity,

1. The $2.8 Trillion Arithmetic: Market Structure and Strategic Stakes The global pharmaceutical market reached approximately $1.6 trillion in 2024

A deep dive covering the ANDA pathway, EU MAA procedures, bioequivalence science, Paragraph IV litigation strategy, patent cliff analysis, evergreening

The $236 Billion Race Most Procurement Teams Are Losing Between 2025 and 2030, more than $236 billion in branded pharmaceutical

I. Market Context: Why the CDMO Sector Is Repricing The global pharmaceutical CDMO market hit approximately $181.93 billion in 2025,